Arrhythmogenic or dilated or desmoplakin cardiomyopathy? A challenging case managed by our multidisciplinary

Priya Chockalingam1, Deep Chandh Raja2, C Sundar3

  • 1Centre for Inherited Heart Disease, Department of Cardiology, Kauvery Hospital, Chennai, India.

Insights

Arrhythmogenic cardiomyopathy (ACM) is a genetic heart condition causing sudden death. This case highlights novel gene mutations (DES, DOLK) in a severe biventricular ACM patient, emphasizing the need for genetic programs in developing nations.

Area of Science:

  • Cardiovascular Genetics
  • Inherited Cardiac Diseases

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is a primary inherited heart muscle disease.
  • It is characterized by fibro-fatty replacement of the myocardium, leading to ventricular arrhythmias and sudden cardiac death, particularly in young, athletic individuals.
  • Genetic factors play a significant role in ACM pathogenesis.

Observation:

  • A case of severe biventricular ACM in a middle-aged male with a family history of premature deaths due to cardiomyopathy.
  • The proband presented with significant cardiac dysfunction and arrhythmias.
  • Diagnostic evaluation revealed a complex clinical picture consistent with advanced ACM.

Findings:

  • Genetic analysis identified two novel mutations in the DES and DOLK genes in the proband.
  • These mutations are implicated in the pathogenesis of arrhythmogenic cardiomyopathy.
  • This finding expands the spectrum of known genetic variants associated with ACM.

Implications:

  • This case underscores the importance of comprehensive genetic evaluation in families with a history of cardiomyopathy and sudden cardiac death.
  • The identification of novel mutations highlights the ongoing need for research into the genetic underpinnings of ACM.
  • Establishing dedicated cardiovascular genetics programs and population-specific genetic databases in developing countries is crucial for improved diagnosis and management of inherited heart diseases.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
932
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909